AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34436611 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID‐19 mitigation measures
Number of subjects: 764
Study 35414092 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT) consisting of eight modules focusing on psychoeducation, cognitive restructuring, pacing, and emotion regulation, with weekly written feedback from a trained therapist.
Number of subjects: 120
Study 35414092 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 120
Study 35414092 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT)
Number of subjects: 120
Study 34488326 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine (100 mg as intravenous infusion)
Number of subjects: 116
Study 34488326 — intervention group
Group type: COMPARATOR
Intervention: Control (routine cares)
Number of subjects: 116
Study 32881912 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (DPP4i) at 100mg daily for 28 days
Number of subjects: 21
Study 32881912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 35655231 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based virtual reality training (MIND-VR and The Secret Garden) consisting of three sessions in one week using Oculus Quest 2.
Number of subjects: 60
Study 35655231 — intervention group
Group type: COMPARATOR
Intervention: Control group with no training.
Number of subjects: 60
Study 32914866 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy
Number of subjects: 444
Study 32914866 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 444
Study 34812982 — intervention group
Group type: COMPARATOR
Intervention: Cytoreductive surgery (CRS) alone
Number of subjects: 71
Study 34812982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 71
Study 34812982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) with or without HIPEC
Number of subjects: 71
Study 33145862 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol alone
Number of subjects: 0
Study 33145862 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose NSAID (piroxicam) alone
Number of subjects: 0
Study 33145862 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol and high-dose NSAID combination
Number of subjects: 0
Study 35616410 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at sensitization points
Number of subjects: 26
Study 35616410 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at CV4
Number of subjects: 26
Study 35616410 — intervention group
Group type: COMPARATOR
Intervention: Control group (corn oil gavage)
Number of subjects: 26
Study 35616410 — intervention group
Group type: EXPERIMENTAL
Intervention: Model group (BPA gavage)
Number of subjects: 26
Study 34189832 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg/day
Number of subjects: 40
Study 34189832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33322280 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% maltodextrin
Number of subjects: 9
Study 33322280 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (20 g/day) and 8% maltodextrin
Number of subjects: 9
Study 33322280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 33322280 — intervention group
Group type: COMPARATOR
Intervention: Hypoxia and placebo
Number of subjects: 9
Study 33322280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia and carbohydrate
Number of subjects: 9
Study 33322280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia and glutamine supplementation
Number of subjects: 9
Study 33322280 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 9
Study 34857545 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitor dapagliflozin (5 mg daily)
Number of subjects: 22
Study 34857545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 32347767 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine (RZV)
Number of subjects: 0
Study 32347767 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine (RZV) post-dose 2
Number of subjects: 0
Study 33915962 — intervention group
Group type: COMPARATOR
Intervention: Reishi Mushroom (lower-dose)
Number of subjects: 29
Study 33915962 — intervention group
Group type: COMPARATOR
Intervention: Reishi Mushroom (higher-dose)
Number of subjects: 29
Study 33915962 — intervention group
Group type: COMPARATOR
Intervention: Stinging Nettle (lower-dose)
Number of subjects: 29
Study 33915962 — intervention group
Group type: COMPARATOR
Intervention: Stinging Nettle (higher-dose)
Number of subjects: 29
Study 33915962 — intervention group
Group type: COMPARATOR
Intervention: Epimedium (lower-dose)
Number of subjects: 29
Study 33915962 — intervention group
Group type: COMPARATOR
Intervention: Epimedium (higher-dose)
Number of subjects: 29
Study 34644471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (48 international units daily)
Number of subjects: 290
Study 34644471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study 34644471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 290
Study 32807447 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedaling exercises for 10 minutes at a load of 5 Nm and rotation speed of 40 rpm
Number of subjects: 21
Study 32807447 — intervention group
Group type: COMPARATOR
Intervention: Walking group (control) for 10 minutes
Number of subjects: 21
Study 36334895 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on radiation protection (RP) performance after each case
Number of subjects: 24
Study 36334895 — intervention group
Group type: COMPARATOR
Intervention: No feedback on radiation protection (RP) performance after each case
Number of subjects: 24
Study 34756606 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodized titanium abutment collars
Number of subjects: 30
Study 34756606 — intervention group
Group type: COMPARATOR
Intervention: Unanodized titanium abutment collars (control)
Number of subjects: 30
Study 34639396 — intervention group
Group type: EXPERIMENTAL
Intervention: Drum playing intervention with rhythmic cueing (DPRC)
Number of subjects: 12
Study 34639396 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study 35833454 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/day, titrated every 3-4 days)
Number of subjects: 11
Study 35833454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 35833454 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 11
Study 33905493 — intervention group
Group type: EXPERIMENTAL
Intervention: 64 mg guanabenz
Number of subjects: 200
Study 33905493 — intervention group
Group type: EXPERIMENTAL
Intervention: 32 mg guanabenz
Number of subjects: 200
Study 33905493 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg guanabenz
Number of subjects: 200
Study 33905493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 33905493 — intervention group
Group type: COMPARATOR
Intervention: Historical cohort
Number of subjects: 200
Study 33905493 — intervention group
Group type: EXPERIMENTAL
Intervention: All guanabenz arms
Number of subjects: 200
Study 35488976 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Parent Training (BPT)
Number of subjects: 38
Study 35488976 — intervention group
Group type: COMPARATOR
Intervention: Active control (psychoeducation/supportive therapy)
Number of subjects: 38
Study 34592135 — intervention group
Group type: EXPERIMENTAL
Intervention: Costochondral graft (CCG)
Number of subjects: 56
Study 34592135 — intervention group
Group type: COMPARATOR
Intervention: Gap arthroplasty (GA)
Number of subjects: 56
Study 34592135 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CCG and GA
Number of subjects: 56
Study 35256635 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasmajet (CAP-jet)
Number of subjects: 78
Study 35256635 — intervention group
Group type: COMPARATOR
Intervention: Best practice wound dressings (BP)
Number of subjects: 78
Study 32169808 — intervention group
Group type: EXPERIMENTAL
Intervention: DCs vaccine (group III)
Number of subjects: 20
Study 32169808 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-arterial chemoembolization (TACE) and DCs as adjuvant therapy (group I)
Number of subjects: 20
Study 32169808 — intervention group
Group type: COMPARATOR
Intervention: Supportive treatment (group IV)
Number of subjects: 20
Study 32169808 — intervention group
Group type: COMPARATOR
Intervention: TACE only (group II)
Number of subjects: 20
Study 33618592 — intervention group
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Number of subjects: 37
Study 33618592 — intervention group
Group type: COMPARATOR
Intervention: Vorinostat
Number of subjects: 37
Study 35141803 — intervention group
Group type: EXPERIMENTAL
Intervention: Sniffing position
Number of subjects: 150
Study 35141803 — intervention group
Group type: COMPARATOR
Intervention: Neutral head position
Number of subjects: 150
Study 35141803 — intervention group
Group type: EXPERIMENTAL
Intervention: Head extension position
Number of subjects: 150
Study 33978070 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated approach including balloon uterine stent placement, artificial cycle, intrauterine perfusion of Danshen injection, and oral Chinese medicine
Number of subjects: 70
Study 33978070 — intervention group
Group type: COMPARATOR
Intervention: Control group with balloon uterine stent placement, artificial cycle, hyaluronic acid sodium, and intrauterine device (IUD)
Number of subjects: 70
Study 32084530 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg or 8 mg)
Number of subjects: 82
Study 32084530 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 82
Study 32084530 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg)
Number of subjects: 82
Study 35064689 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile graphic book with audio and teacher supervision (ATB/TS) group
Number of subjects: 40
Study 35064689 — intervention group
Group type: COMPARATOR
Intervention: Audio/hands-on (A/HO) group
Number of subjects: 40
Study 33030584 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) group
Number of subjects: 104
Study 33030584 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 35030476 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR gene polymorphism (rs2274976)
Number of subjects: 168
Study 35030476 — intervention group
Group type: COMPARATOR
Intervention: AGT gene polymorphism (rs699)
Number of subjects: 168
Study 35030476 — intervention group
Group type: COMPARATOR
Intervention: VEGF gene polymorphism (rs3025035)
Number of subjects: 168
Study 35030476 — intervention group
Group type: COMPARATOR
Intervention: VEGF gene polymorphism (rs3024987)
Number of subjects: 168
Study 35030476 — intervention group
Group type: COMPARATOR
Intervention: VEGF gene polymorphism (rs3025039)
Number of subjects: 168
Study 32351164 — intervention group
Group type: EXPERIMENTAL
Intervention: Ublituximab (150 mg over 1–4 hours on day 1 and 450–600 mg over 1–3 hours on day 15 and week 24)
Number of subjects: 48
Study 32351164 — intervention group
Group type: EXPERIMENTAL
Intervention: Ublituximab
Number of subjects: 48
Study 33241542 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric quadriceps exercise with auditory and visual feedback
Number of subjects: 62
Study 33241542 — intervention group
Group type: COMPARATOR
Intervention: Standardized program for TKA
Number of subjects: 62
Study 33836810 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaccompanied course (no support from psychologist via weekly phone calls)
Number of subjects: 400
Study 33836810 — intervention group
Group type: EXPERIMENTAL
Intervention: Accompanied course (support from a psychologist via weekly phone calls)
Number of subjects: 400
Study 33836810 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (access to the intervention after 24 weeks)
Number of subjects: 400
Study 32743950 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Buddy intervention group (N = 20)
Number of subjects: 48
Study 32743950 — intervention group
Group type: COMPARATOR
Intervention: Attention control group (N = 28)
Number of subjects: 48
Study 32743950 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study 36484872 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic capsule containing 6 × 10^9 CFU Lactobacillus coagulans SC‐208, 6 × 10^9 CFU Lactobacillus indicus HU36 and fructooligosaccharide as a prebiotic, taken twice a day for eight weeks
Number of subjects: 60
Study 36484872 — intervention group
Group type: COMPARATOR
Intervention: Placebo, taken twice a day for eight weeks
Number of subjects: 60
Study 33565694 — intervention group
Group type: EXPERIMENTAL
Intervention: Numerical descriptor only (4% alcohol by volume (ABV))
Number of subjects: 147
Study 33565694 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined verbal and numerical descriptor (Super Low 4%ABV)
Number of subjects: 147
Study 33565694 — intervention group
Group type: COMPARATOR
Intervention: Verbal descriptor only (Super Low)
Number of subjects: 147
Study 33771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal exercise (150 min of moderate‐intensity weekly exercise)
Number of subjects: 125
Study 33771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal exercise
Number of subjects: 125
Study 33771102 — intervention group
Group type: COMPARATOR
Intervention: Non‐exercising controls (low‐intensity stretching/breathing sessions)
Number of subjects: 125
Study 35235774 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 1,000 mg
Number of subjects: 30
Study 35235774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34233644 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ultrasound (EUS)
Number of subjects: 325
Study 34233644 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone App
Number of subjects: 325
Study 34233644 — intervention group
Group type: EXPERIMENTAL
Intervention: Last Menstrual Period (LMP)
Number of subjects: 325
Study 34030185 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical evacuation of the hematoma
Number of subjects: 159
Study 34030185 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative management (no surgical evacuation)
Number of subjects: 159
Study 34030185 — intervention group
Group type: COMPARATOR
Intervention: STICH II surgical cohort
Number of subjects: 159
Study 34030185 — intervention group
Group type: COMPARATOR
Intervention: STICH II conservative cohort
Number of subjects: 159
Study 34030185 — intervention group
Group type: COMPARATOR
Intervention: MISTIE III surgical cohort
Number of subjects: 159
Study 34030185 — intervention group
Group type: COMPARATOR
Intervention: MISTIE III conservative cohort
Number of subjects: 159
Study 34030185 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic model using random forest classifier
Number of subjects: 159
Study 34725039 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based lifestyle intervention (9 visits and 13 telephone contacts over 1 year)
Number of subjects: 3684
Study 34725039 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based lifestyle intervention
Number of subjects: 3684
Study 34725039 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 3684
Study 35341156 — intervention group
Group type: EXPERIMENTAL
Intervention: RG group (general treatments combining reduced glutathione)
Number of subjects: 162
Study 35341156 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF group (general treatments combining Chuan Huang Fang)
Number of subjects: 162
Study 35341156 — intervention group
Group type: EXPERIMENTAL
Intervention: RG + CHF group (general treatments combining reduced glutathione and Chuan Huang Fang)
Number of subjects: 162
Study 35341156 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 162
Study 33214162 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition virtual chromoendoscopy (HDV)
Number of subjects: 188
Study 33214162 — intervention group
Group type: COMPARATOR
Intervention: High-definition white light (HDWL)
Number of subjects: 188
Study 33561357 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based auditory training
Number of subjects: 0
Study 33561357 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 33136134 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron supplements plus 200 mg of vitamin C
Number of subjects: 440
Study 33136134 — intervention group
Group type: COMPARATOR
Intervention: Oral iron supplements only
Number of subjects: 440
Study 36207714 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR
Number of subjects: 146
Study 36207714 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal intubation
Number of subjects: 146
Study 36207714 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed competence and willingness
Number of subjects: 146
Study 36207714 — intervention group
Group type: EXPERIMENTAL
Intervention: Training satisfaction
Number of subjects: 146
Study 34221029 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing students
Number of subjects: 580
Study 34221029 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical students
Number of subjects: 580
Study 34221029 — intervention group
Group type: COMPARATOR
Intervention: Comparison between nursing and medical students
Number of subjects: 580
Study 34967656 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive therapy in addition to conventional heart failure therapy
Number of subjects: 20
Study 34967656 — intervention group
Group type: COMPARATOR
Intervention: Conventional heart failure therapy alone
Number of subjects: 20
Study 33849606 — intervention group
Group type: EXPERIMENTAL
Intervention: IOERT (10 Gy)
Number of subjects: 245
Study 33849606 — intervention group
Group type: COMPARATOR
Intervention: EBRT (5 × 2 Gy)
Number of subjects: 245
Study 33172465 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigger errors in mechanically ventilated children
Number of subjects: 28
Study 33172465 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher spontaneous breath rate
Number of subjects: 28
Study 33172465 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-ventilator asynchrony
Number of subjects: 28
Study 36067336 — intervention group
Group type: EXPERIMENTAL
Intervention: REThink game without guidance
Number of subjects: 139
Study 36067336 — intervention group
Group type: EXPERIMENTAL
Intervention: REThink game with guidance
Number of subjects: 139
Study 36067336 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual control group
Number of subjects: 139
Study 35753441 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful eating programme
Number of subjects: 284
Study 35753441 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness programme
Number of subjects: 284
Study 35753441 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 284
Study 33984574 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep group (normal sleep between pretest and posttest)
Number of subjects: 89
Study 33984574 — intervention group
Group type: COMPARATOR
Intervention: Wake group (12 hours awake during the day)
Number of subjects: 89
Study 33984574 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (sleep and wake)
Number of subjects: 89
Study 32546962 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC of fimasartan 120 mg and atorvastatin 40 mg
Number of subjects: 56
Study 32546962 — intervention group
Group type: COMPARATOR
Intervention: Separate tablets of fimasartan and atorvastatin
Number of subjects: 56
Study 32892246 — intervention group
Group type: EXPERIMENTAL
Intervention: IL BTX‐A
Number of subjects: 50
Study 32892246 — intervention group
Group type: COMPARATOR
Intervention: IL 5‐FU
Number of subjects: 50
Study 34180843 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation about the futility of antibiotic treatment of URTIs
Number of subjects: 0
Study 34180843 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation about the adverse effects associated with antibiotics
Number of subjects: 0
Study 34180843 — intervention group
Group type: COMPARATOR
Intervention: Active control (presentation about benefits of healthy diet and exercise)
Number of subjects: 0
Study 32031887 — intervention group
Group type: EXPERIMENTAL
Intervention: Early integrated palliative and oncology care (PC), with expected monthly meetings with a PC clinician until death.
Number of subjects: 391
Study 32031887 — intervention group
Group type: COMPARATOR
Intervention: Usual oncology care, with PC consultations on request.
Number of subjects: 391
Study 34360028 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 30
Study 34360028 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballistic Training (BT)
Number of subjects: 30
Study 34360028 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 30
Study 32349759 — intervention group
Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI) > 5
Number of subjects: 4856
Study 32349759 — intervention group
Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI) > 8
Number of subjects: 4856
Study 32349759 — intervention group
Group type: EXPERIMENTAL
Intervention: Average PSQI score
Number of subjects: 4856
Study 32349759 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiary hospitals
Number of subjects: 4856
Study 32349759 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary hospitals
Number of subjects: 4856
Study 32349759 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary hospitals
Number of subjects: 4856
Study 616841197 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 47
Study 616841197 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 47
Study 36041655 — intervention group
Group type: EXPERIMENTAL
Intervention: Astegolimab 490 mg every 4 weeks for 16 weeks
Number of subjects: 65
Study 36041655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 33468118 — intervention group
Group type: EXPERIMENTAL
Intervention: Expository writing (EW)
Number of subjects: 139